# SSR Mining Inc.: financial statements, quarterly

SSRM · Nasdaq · CIK 921638 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ssrm.md) · [Financials](/companies/ssrm/financials.md) · [Filings](/companies/ssrm/filings.md) · [Insiders](/companies/ssrm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ssrm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [385](/filings/0000921638-23-000222.md) | [414 d](/filings/0000921638-26-000035.md) | [230](/filings/0000921638-25-000112.md) | [185](/filings/0000921638-25-000161.md) | [257](/filings/0000921638-25-000197.md) | [315 d](/filings/0000921638-26-000035.md) | [317](/filings/0000921638-26-000062.md) | [405](/filings/0000921638-26-000081.md) | [386](/filings/0000921638-25-000197.md) | [495 d](/filings/0000921638-26-000035.md) | [582](/filings/0000921638-26-000062.md) | [444](/filings/0000921638-26-000081.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [77.5](/filings/0000921638-24-000190.md) | [(298) d](/filings/0000921638-26-000035.md) | [(376)](/filings/0000921638-25-000112.md) | [10.7](/filings/0000921638-25-000161.md) | [9.0](/filings/0000921638-25-000197.md) | [34.4 d](/filings/0000921638-26-000035.md) | [107](/filings/0000921638-26-000062.md) | [168](/filings/0000921638-26-000081.md) | [83.3](/filings/0000921638-25-000197.md) | [202 d](/filings/0000921638-26-000035.md) | [300](/filings/0000921638-26-000062.md) | [192](/filings/0000921638-26-000081.md) |
| Interest expense | $m | [4.1](/filings/0000921638-23-000222.md) | [2.5 d](/filings/0000921638-24-000047.md) | [4.7](/filings/0000921638-24-000115.md) | [2.1](/filings/0000921638-25-000161.md) | [2.9](/filings/0000921638-25-000197.md) | [3.3 d](/filings/0000921638-26-000035.md) | [1.8](/filings/0000921638-26-000062.md) | [0.0](/filings/0000921638-26-000081.md) | [3.6](/filings/0000921638-25-000197.md) | [3.4 d](/filings/0000921638-26-000035.md) | [1.3](/filings/0000921638-26-000062.md) | [0.5](/filings/0000921638-26-000081.md) |
| Income tax | $m | [68.9](/filings/0000921638-24-000190.md) | [(70.8) d](/filings/0000921638-26-000035.md) | [(20.2)](/filings/0000921638-25-000112.md) | [11.7](/filings/0000921638-25-000161.md) | [0.9](/filings/0000921638-25-000197.md) | [40.9 d](/filings/0000921638-26-000035.md) | [16.4](/filings/0000921638-26-000062.md) | [29.3](/filings/0000921638-26-000081.md) | [15.0](/filings/0000921638-25-000197.md) | [35.9 d](/filings/0000921638-26-000035.md) | [59.8](/filings/0000921638-26-000062.md) | [48.3](/filings/0000921638-26-000081.md) |
| Net income | $m | [15.2](/filings/0000921638-24-000190.md) | [(218) d](/filings/0000921638-26-000035.md) | [(287)](/filings/0000921638-25-000112.md) | [9.7](/filings/0000921638-25-000161.md) | [10.6](/filings/0000921638-25-000197.md) | [5.6 d](/filings/0000921638-26-000035.md) | [58.8](/filings/0000921638-26-000062.md) | [90.1](/filings/0000921638-26-000081.md) | [65.4](/filings/0000921638-25-000197.md) | [181 d](/filings/0000921638-26-000035.md) | [(106)](/filings/0000921638-26-000062.md) | [97.3](/filings/0000921638-26-000081.md) |
| Diluted EPS | $ per share | [0.07](/filings/0000921638-24-000190.md) | not reported | [(1.42)](/filings/0000921638-25-000112.md) | [0.05](/filings/0000921638-25-000161.md) | [0.05](/filings/0000921638-25-000197.md) | not reported | [0.28](/filings/0000921638-26-000062.md) | [0.42](/filings/0000921638-26-000081.md) | [0.31](/filings/0000921638-25-000197.md) | not reported | [(0.52)](/filings/0000921638-26-000062.md) | [0.47](/filings/0000921638-26-000081.md) |
| Basic EPS | $ per share | [0.07](/filings/0000921638-24-000190.md) | not reported | [(1.42)](/filings/0000921638-25-000112.md) | [0.05](/filings/0000921638-25-000161.md) | [0.05](/filings/0000921638-25-000197.md) | not reported | [0.29](/filings/0000921638-26-000062.md) | [0.44](/filings/0000921638-26-000081.md) | [0.32](/filings/0000921638-25-000197.md) | not reported | [(0.52)](/filings/0000921638-26-000062.md) | [0.47](/filings/0000921638-26-000081.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Cost of revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [438](/filings/0000921638-24-000190.md) | [492](/filings/0000921638-26-000035.md) | [467](/filings/0000921638-25-000112.md) | [358](/filings/0000921638-25-000161.md) | [334](/filings/0000921638-25-000197.md) | [388](/filings/0000921638-26-000035.md) | [320](/filings/0000921638-25-000112.md) | [412](/filings/0000921638-25-000161.md) | [409](/filings/0000921638-25-000197.md) | [516](/filings/0000921638-26-000081.md) | [634](/filings/0000921638-26-000062.md) | [1,783](/filings/0000921638-26-000081.md) |
| Current assets | $m | [1,158](/filings/0000921638-23-000222.md) | [1,196](/filings/0000921638-25-000041.md) | [1,082](/filings/0000921638-24-000115.md) | [1,022](/filings/0000921638-24-000145.md) | [996](/filings/0000921638-24-000190.md) | [1,029](/filings/0000921638-26-000035.md) | [1,025](/filings/0000921638-25-000112.md) | [1,147](/filings/0000921638-25-000161.md) | [1,206](/filings/0000921638-25-000197.md) | [1,287](/filings/0000921638-26-000081.md) | [3,669](/filings/0000921638-26-000062.md) | [2,469](/filings/0000921638-26-000081.md) |
| Total assets | $m | [5,750](/filings/0000921638-24-000190.md) | [5,386](/filings/0000921638-26-000035.md) | [5,252](/filings/0000921638-25-000112.md) | [5,176](/filings/0000921638-25-000161.md) | [5,144](/filings/0000921638-25-000197.md) | [5,189](/filings/0000921638-26-000035.md) | [5,645](/filings/0000921638-25-000112.md) | [5,796](/filings/0000921638-25-000161.md) | [5,908](/filings/0000921638-25-000197.md) | [6,094](/filings/0000921638-26-000081.md) | [5,947](/filings/0000921638-26-000062.md) | [4,279](/filings/0000921638-26-000081.md) |
| Current liabilities | $m | [166](/filings/0000921638-23-000222.md) | [171](/filings/0000921638-25-000041.md) | [353](/filings/0000921638-24-000115.md) | [289](/filings/0000921638-24-000145.md) | [255](/filings/0000921638-24-000190.md) | [219](/filings/0000921638-26-000035.md) | [260](/filings/0000921638-25-000112.md) | [481](/filings/0000921638-25-000161.md) | [501](/filings/0000921638-25-000197.md) | [618](/filings/0000921638-26-000081.md) | [689](/filings/0000921638-26-000062.md) | [252](/filings/0000921638-26-000081.md) |
| Total liabilities | $m | [1,157](/filings/0000921638-23-000222.md) | [1,082](/filings/0000921638-25-000041.md) | [1,313](/filings/0000921638-24-000115.md) | [1,234](/filings/0000921638-24-000145.md) | [1,195](/filings/0000921638-24-000190.md) | [1,242](/filings/0000921638-26-000035.md) | [1,641](/filings/0000921638-25-000112.md) | [1,710](/filings/0000921638-25-000161.md) | [1,763](/filings/0000921638-25-000197.md) | [1,780](/filings/0000921638-26-000081.md) | [1,518](/filings/0000921638-26-000062.md) | [888](/filings/0000921638-26-000081.md) |
| Long-term debt | $m | [227](/filings/0000921638-23-000222.md) | [228](/filings/0000921638-24-000145.md) | [228](/filings/0000921638-24-000115.md) | [228](/filings/0000921638-24-000145.md) | [228](/filings/0000921638-24-000190.md) | [229](/filings/0000921638-25-000041.md) | not reported | not reported | not reported | [51.4](/filings/0000921638-26-000062.md) | [66.1](/filings/0000921638-26-000062.md) | not reported |
| Current portion of debt | $m | [0.9](/filings/0000921638-23-000222.md) | [0.9](/filings/0000921638-24-000145.md) | [1.0](/filings/0000921638-24-000115.md) | [0.0](/filings/0000921638-24-000145.md) | not reported | [11.0](/filings/0000921638-25-000112.md) | [11.0](/filings/0000921638-25-000112.md) | not reported | not reported | [230](/filings/0000921638-26-000081.md) | [0.0](/filings/0000921638-26-000062.md) | [0.0](/filings/0000921638-26-000081.md) |
| Shareholders' equity | $m | [3,615](/filings/0000921638-23-000222.md) | [3,373](/filings/0000921638-25-000041.md) | [3,079](/filings/0000921638-24-000115.md) | [3,088](/filings/0000921638-24-000145.md) | [3,100](/filings/0000921638-24-000190.md) | [3,107](/filings/0000921638-26-000035.md) | [3,168](/filings/0000921638-25-000112.md) | [3,260](/filings/0000921638-25-000161.md) | [3,327](/filings/0000921638-25-000197.md) | [3,508](/filings/0000921638-26-000081.md) | [3,631](/filings/0000921638-26-000062.md) | [3,392](/filings/0000921638-26-000081.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [135 d](/filings/0000921638-24-000190.md) | [203 d](/filings/0000921638-26-000035.md) | [24.6](/filings/0000921638-25-000112.md) | [(78.1) d](/filings/0000921638-25-000161.md) | [(1.3) d](/filings/0000921638-25-000197.md) | [95.0 d](/filings/0000921638-26-000035.md) | [82.3](/filings/0000921638-26-000062.md) | [158 d](/filings/0000921638-26-000081.md) | [59.9 d](/filings/0000921638-25-000197.md) | [172 d](/filings/0000921638-26-000035.md) | [264](/filings/0000921638-26-000062.md) | [100 d](/filings/0000921638-26-000081.md) |
| Capital expenditure | $m | [54.2](/filings/0000921638-24-000190.md) | [58.8 d](/filings/0000921638-26-000035.md) | [34.0](/filings/0000921638-25-000112.md) | [36.3](/filings/0000921638-25-000161.md) | [31.7](/filings/0000921638-25-000197.md) | [38.6 d](/filings/0000921638-26-000035.md) | [44.8](/filings/0000921638-26-000062.md) | [62.5](/filings/0000921638-25-000161.md) | [57.7](/filings/0000921638-25-000197.md) | [65.7 d](/filings/0000921638-26-000035.md) | [88.8](/filings/0000921638-26-000062.md) | [32.5 d](/filings/0000921638-26-000081.md) |
| Dividends paid | $m | [14.4 d](/filings/0000921638-24-000190.md) | [14.5 d](/filings/0000921638-26-000035.md) | [0.0](/filings/0000921638-24-000115.md) | [0.0 d](/filings/0000921638-24-000145.md) | [0.0 d](/filings/0000921638-24-000190.md) | [0.0 d](/filings/0000921638-26-000035.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [0.0 d](/filings/0000921638-24-000190.md) | [11.0 d](/filings/0000921638-26-000035.md) | [9.8](/filings/0000921638-25-000112.md) | [0.0 d](/filings/0000921638-25-000161.md) | [0.0 d](/filings/0000921638-25-000197.md) | [0.0 d](/filings/0000921638-26-000035.md) | [0.0](/filings/0000921638-25-000112.md) | [0.0 d](/filings/0000921638-26-000081.md) | [0.0 d](/filings/0000921638-25-000197.md) | [0.0 d](/filings/0000921638-26-000035.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets, us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [208](/filings/0000921638-23-000222.md) | [219](/filings/0000921638-24-000115.md) | [217](/filings/0000921638-24-000145.md) | [204](/filings/0000921638-24-000190.md) | [202](/filings/0000921638-25-000112.md) | [202](/filings/0000921638-25-000161.md) | [202](/filings/0000921638-25-000197.md) | [217](/filings/0000921638-26-000062.md) | [217](/filings/0000921638-26-000081.md) | [217](/filings/0000921638-25-000197.md) | [218](/filings/0000921638-26-000062.md) | [209](/filings/0000921638-26-000081.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 203,909,312 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0000921638-26-000081.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.